한글목차

항균제 내성 감시 시장의 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 73억 달러에서 2026년에는 79억 1,000만 달러로, CAGR 8.4%로 확대가 전망되고 있습니다. 지난 수년간의 성장에는 약제 내성 감염 증가, 병원내 감염 대책, 공중보건 감시 프로그램, 검사 체계의 확대, 항생제 오남용에 대한 우려 등이 주요 요인으로 꼽힙니다.

항균제 내성 감시 시장의 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 108억 5,000만 달러에 달하며, CAGR은 8.2%에 달할 전망입니다. 예측 기간의 성장에는 세계 AMR 모니터링 구상, AI를 활용한 예측 모니터링, 클라우드 기반 데이터 공유, 유전체 모니터링의 확대, 정책 주도 보고 의무화 등이 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 실시간 내성 패턴 모니터링, 전장 유전체 염기서열 모니터링, AI 기반 내성 분석, 통합 공중보건 데이터베이스, 병원 전체 AMR 추적 시스템 등을 들 수 있습니다.

감염성 질환 증가 추세는 항균제 내성 모니터링 시장의 성장을 가속할 것으로 예측됩니다. 감염은 세균, 바이러스, 곰팡이, 기생충 등 유해한 미생물에 의해 발생하며, 개인 간 직간접적으로 전파됩니다. 기후 변화, 도시화, 국제 이동 등의 요인은 병원균의 전파를 촉진하고 새로운 미생물에 대한 노출 기회를 증가시킴으로써 이러한 질병 증가에 기여하고 있습니다. 항균제 내성 모니터링은 내성 병원체의 확산을 추적하고, 효과적인 치료 전략을 수립하고, 감염병 대응을 위한 공중보건 정책을 수립하는 데 있으며, 매우 중요한 역할을 합니다. 예를 들어 2024년 2월 영국 보건안전청이 발표한 보고서에 따르면 영국내 결핵(TB) 발병 건수는 전년 대비 10.7% 증가하여 2023년 4,850건(2022년 4,380건)으로 보고되었습니다. 이러한 감염성 질환의 확산은 항균제 내성 모니터링 시장의 성장을 촉진하고 있습니다.

업계 주요 기업은 효율성 향상, 정확성 강화, 비용 절감 및 환자 치료 결과 개선을 위해 첨단 진단 툴와 같은 혁신적인 기술에 집중하고 있습니다. 진단 툴은 상태, 질병 또는 기능 장애의 유무를 감지, 식별 또는 평가하기 위해 사용되는 모든 장치, 기기, 소프트웨어 또는 조사 방법을 말합니다. 예를 들어 2023년 6월 스웨덴에 본사를 둔 진단 제품 제조업체인 Sysmex Astrego AB는 PA-100 AST Point-of-Care 검사 시스템을 발표했습니다. 이 시스템은 진료 현장에서 항균제 내성을 신속하고 정확하게 검출할 수 있으며, 며칠이 소요되는 기존 검사실 방식에 비해 결과 도출 시간을 크게 단축할 수 있습니다. 단 30분 만에 결과를 제공함으로써 임상의는 감염 치료에 대한 정보에 기반한 적시 판단을 내릴 수 있으며, 광범위 항생제 의존도를 최소화하고 항균제 내성 억제를 위한 노력을 지원할 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Antimicrobial resistance (AMR) surveillance involves the systematic monitoring and tracking of antimicrobial-resistant microorganisms to detect emerging resistance patterns, guide public health interventions, and inform treatment strategies for infections caused by resistant bacteria, viruses, and fungi.

The primary solutions in AMR surveillance include diagnostic kits, diagnostic systems, surveillance software, and services. Diagnostic kits are pre-packaged tools that enable healthcare professionals to rapidly identify antimicrobial-resistant infections in patients. These solutions are applied in clinical diagnostics, public health surveillance, and other areas, serving end users such as hospitals and clinics, research and academic institutes, and other healthcare facilities.

Tariffs are impacting the antimicrobial resistance surveillance market by increasing costs of sequencing systems, diagnostic kits, and data analytics infrastructure. Genomic and AI-based surveillance solutions are most affected, particularly in regions dependent on imported laboratory equipment. Conversely, tariffs have supported regional lab capacity building and software-driven surveillance adoption.

The antimicrobial resistance surveillance market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance surveillance market statistics, including antimicrobial resistance surveillance industry global market size, regional shares, competitors with a antimicrobial resistance surveillance market share, detailed antimicrobial resistance surveillance market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance surveillance industry. This antimicrobial resistance surveillance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antimicrobial resistance surveillance market size has grown strongly in recent years. It will grow from $7.3 billion in 2025 to $7.91 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rise in drug-resistant infections, hospital infection control initiatives, public health surveillance programs, laboratory testing expansion, antibiotic misuse concerns.

The antimicrobial resistance surveillance market size is expected to see strong growth in the next few years. It will grow to $10.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to global AMR monitoring initiatives, AI-driven predictive surveillance, cloud-based data sharing, genomic surveillance growth, policy-driven reporting mandates. Major trends in the forecast period include real-time resistance pattern monitoring, whole genome sequencing surveillance, AI-based resistance analytics, integrated public health databases, hospital-wide AMR tracking systems.

The increasing prevalence of infectious diseases is expected to drive the growth of the antimicrobial resistance surveillance market. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites and can spread directly or indirectly between individuals. Factors such as climate change, urbanization, and global travel contribute to the rising prevalence of these diseases by facilitating pathogen transmission and increasing human exposure to new microbes. Antimicrobial resistance surveillance plays a crucial role in tracking the spread of resistant pathogens, guiding effective treatment strategies, and shaping public health policies to combat infectious diseases. For example, in February 2024, a report by the UK Health Security Agency revealed a 10.7% increase in tuberculosis (TB) cases in England, with 4,850 cases reported in 2023 compared to 4,380 in 2022. As a result, the increasing prevalence of infectious diseases is fueling the expansion of the antimicrobial resistance surveillance market.

Leading companies in the industry are focusing on innovative technologies, such as advanced diagnostic tools, to improve efficiency, enhance accuracy, reduce costs, and provide better patient outcomes. A diagnostic tool encompasses any device, instrument, software, or methodology used to detect, identify, or assess the presence of a condition, disease, or malfunction. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer of diagnostic products, launched the PA-100 AST Point-of-Care Testing System. This system enables rapid and precise detection of antimicrobial resistance at the point of care, significantly reducing the time required for results compared to conventional laboratory methods, which can take several days. By delivering results in just 30 minutes, it empowers clinicians to make timely and informed decisions regarding infection treatment, minimizing reliance on broad-spectrum antibiotics and aiding efforts to curb antimicrobial resistance.

In January 2024, BioMerieux S.A., a France-based biotechnology company, acquired LUMED for an undisclosed amount. This acquisition is aimed at enhancing BioMerieux's capabilities in combating antimicrobial resistance and strengthening its portfolio, particularly by offering digital tools to support antibiotic stewardship. LUMED Inc., an Italy-based company, specializes in healthcare and medical data analysis, with a focus on antimicrobial resistance surveillance.

Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.

North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antimicrobial resistance surveillance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The antimicrobial resistance (AMR) surveillance market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance data collection and analysis, antimicrobial stewardship programs, and infection control and prevention services. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance (AMR) surveillance market also includes sales of diagnostic equipment and tools, antimicrobial agents, laboratory instruments, and software and data analytics platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antimicrobial Resistance Surveillance Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses antimicrobial resistance surveillance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antimicrobial resistance surveillance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial resistance surveillance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Solution: Diagnostic Kits; Diagnostic Systems; Surveillance Software; Services
• 2) By Application: Clinical Diagnostics; Public Health Surveillance; Other Applications
• 3) By End User: Hospitals And Clinics; Research And Academic Institutes; Other End Users
• Subsegments:
• 1) By Diagnostic Kits: PCR-Based Kits; Immunoassay Kits; Lateral Flow Assay Kits
• 2) By Diagnostic Systems: Automated Susceptibility Testing Systems; Whole Genome Sequencing (WGS) Systems; Mass Spectrometry-Based Systems
• 3) By Surveillance Software: Cloud-Based Surveillance Platforms; AI-Powered Data Analytics Tools; Electronic Health Record (EHR)-Integrated Systems
• 4) By Services: Laboratory Testing Services; Data Management & Reporting Services; Consultation & Training Services
• Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton Dickinson and Company; bioMerieux SA; Bio-Rad Laboratories Inc.; Bruker Corporation; QIAGEN NV; Cepheid Inc.; Accelerate Diagnostics Inc.; Liofilchem S.r.l.; Luminex Corporation; Sysmex Corporation; Werfen; OpGen Inc.; Illumina Inc.; Oxford Nanopore Technologies plc; Himedia Laboratories Pvt. Ltd.; Alifax S.r.l.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Antimicrobial Resistance Surveillance Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Antimicrobial Resistance Surveillance Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Antimicrobial Resistance Surveillance Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Antimicrobial Resistance Surveillance Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Real-Time Resistance Pattern Monitoring
  • 4.2.2 Whole Genome Sequencing Surveillance
  • 4.2.3 Ai-Based Resistance Analytics
  • 4.2.4 Integrated Public Health Databases
  • 4.2.5 Hospital-Wide Amr Tracking Systems

5. Antimicrobial Resistance Surveillance Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Public Health Agencies
• 5.3 Research And Academic Institutes
• 5.4 Diagnostic Laboratories
• 5.5 Government Health Departments

6. Antimicrobial Resistance Surveillance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Antimicrobial Resistance Surveillance Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Antimicrobial Resistance Surveillance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Antimicrobial Resistance Surveillance Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Antimicrobial Resistance Surveillance Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Antimicrobial Resistance Surveillance Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Antimicrobial Resistance Surveillance Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Antimicrobial Resistance Surveillance Market Segmentation

• 9.1. Global Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
• 9.2. Global Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Diagnostics, Public Health Surveillance, Other Applications
• 9.3. Global Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Research And Academic Institutes, Other End Users
• 9.4. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
• 9.5. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
• 9.6. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Surveillance Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
• 9.7. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services

10. Antimicrobial Resistance Surveillance Market Regional And Country Analysis

• 10.1. Global Antimicrobial Resistance Surveillance Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Antimicrobial Resistance Surveillance Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Antimicrobial Resistance Surveillance Market

• 11.1. Asia-Pacific Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Antimicrobial Resistance Surveillance Market

• 12.1. China Antimicrobial Resistance Surveillance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Antimicrobial Resistance Surveillance Market

• 13.1. India Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Antimicrobial Resistance Surveillance Market

• 14.1. Japan Antimicrobial Resistance Surveillance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Antimicrobial Resistance Surveillance Market

• 15.1. Australia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Antimicrobial Resistance Surveillance Market

• 16.1. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Antimicrobial Resistance Surveillance Market

• 17.1. South Korea Antimicrobial Resistance Surveillance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Antimicrobial Resistance Surveillance Market

• 18.1. Taiwan Antimicrobial Resistance Surveillance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Antimicrobial Resistance Surveillance Market

• 19.1. South East Asia Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Antimicrobial Resistance Surveillance Market

• 20.1. Western Europe Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Antimicrobial Resistance Surveillance Market

• 21.1. UK Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Antimicrobial Resistance Surveillance Market

• 22.1. Germany Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Antimicrobial Resistance Surveillance Market

• 23.1. France Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Antimicrobial Resistance Surveillance Market

• 24.1. Italy Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Antimicrobial Resistance Surveillance Market

• 25.1. Spain Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Antimicrobial Resistance Surveillance Market

• 26.1. Eastern Europe Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Antimicrobial Resistance Surveillance Market

• 27.1. Russia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Antimicrobial Resistance Surveillance Market

• 28.1. North America Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Antimicrobial Resistance Surveillance Market

• 29.1. USA Antimicrobial Resistance Surveillance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Antimicrobial Resistance Surveillance Market

• 30.1. Canada Antimicrobial Resistance Surveillance Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Antimicrobial Resistance Surveillance Market

• 31.1. South America Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Antimicrobial Resistance Surveillance Market

• 32.1. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Antimicrobial Resistance Surveillance Market

• 33.1. Middle East Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Antimicrobial Resistance Surveillance Market

• 34.1. Africa Antimicrobial Resistance Surveillance Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Antimicrobial Resistance Surveillance Market Regulatory and Investment Landscape

36. Antimicrobial Resistance Surveillance Market Competitive Landscape And Company Profiles

• 36.1. Antimicrobial Resistance Surveillance Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Antimicrobial Resistance Surveillance Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Antimicrobial Resistance Surveillance Market Company Profiles
  • 36.3.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Antimicrobial Resistance Surveillance Market Other Major And Innovative Companies

• bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.

38. Global Antimicrobial Resistance Surveillance Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Antimicrobial Resistance Surveillance Market

40. Antimicrobial Resistance Surveillance Market High Potential Countries, Segments and Strategies

• 40.1 Antimicrobial Resistance Surveillance Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Antimicrobial Resistance Surveillance Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Antimicrobial Resistance Surveillance Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer